Literature DB >> 29264357

Intensive care unit-acquired Acinetobacter baumannii infections in a Moroccan teaching hospital: epidemiology, risk factors and outcome.

Jean Uwingabiye1, Abdelhay Lemnouer2, Sabina Baidoo1, Mohammed Frikh2, Jalal Kasouati2, Adil Maleb1, Yassine Benlahlou1, Fatna Bssaibis3, Albert Mbayo4, Nawfal Doghmi4, Khalil Abouelalaa4, Abdelouahed Baite4, Azeddine Ibrahimi5, Mostafa Elouennass2.   

Abstract

INTRODUCTION: The objective of this study was to examine the epidemiology, risk factors and outcome associated with Acinetobacter baumannii infections in the intensive care units (ICUs) in a Moroccan teaching hospital.
METHODS: This is a matched case-control study conducted as a joint collaboration between the clinical Bacteriology department and the two ICUs of Mohammed V Military Teaching Hospital from January 2015 to July 2016.
RESULTS: Among 964 patients hospitalized in the ICUs, 81 (8.4%) developed A. baumannii infections. Multivariate logistic regression analysis identified the following independent risk factors for ICU-acquired A. baumannii infections: ICU stay ≥14 days (odds ratio (OR)=6.4), prior use of central venous catheters (OR=18), prior use of mechanical ventilation (OR=9.5), duration of invasive procedures ≥7 days (OR=7.8), previous exposure to imipenem (OR=9.1), previous exposure to amikacin (OR=5.2), previous exposure to antibiotic polytherapy (OR=11.8) and previous exposure to corticotherapy (OR=5). On the other hand, the admission for post-operative care was identified as a protective factor. The crude mortality in patients with A. baumannii infection was 74.1%. Multivariate analysis showed that septic shock (OR=19.2) and older age (≥65 years) (OR=4.9) were significantly associated to mortality risk in patients with A. baumannii infection.
CONCLUSION: Our results show that shortening the ICU stay, rational use of medical devices and optimizing antimicrobial therapy could reduce the incidence of these infections. Elderly patients and those with septic shock have a poor prognosis. These findings highlight the need for focusing on the high-risk patients to prevent these infections and improve clinical outcome.

Entities:  

Keywords:  Acinetobacter baumannii; epidemiology; infection; intensive care unit; prognostic factor; risk factors

Year:  2017        PMID: 29264357      PMCID: PMC5734929          DOI: 10.18683/germs.2017.1126

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  31 in total

1.  Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.

Authors:  M del Mar Tomas; M Cartelle; S Pertega; A Beceiro; P Llinares; D Canle; F Molina; R Villanueva; J M Cisneros; G Bou
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

2.  Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study.

Authors:  J M Cisneros; J Rodríguez-Baño; F Fernández-Cuenca; A Ribera; J Vila; A Pascual; L Martínez-Martínez; G Bou; J Pachón
Journal:  Clin Microbiol Infect       Date:  2005-11       Impact factor: 8.067

Review 3.  An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics.

Authors:  Zahra Kassamali; Rupali Jain; Larry H Danziger
Journal:  Int J Infect Dis       Date:  2014-11-05       Impact factor: 3.623

4.  Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Authors:  Rebecca H Sunenshine; Marc-Oliver Wright; Lisa L Maragakis; Anthony D Harris; Xiaoyan Song; Joan Hebden; Sara E Cosgrove; Ashley Anderson; Jennifer Carnell; Daniel B Jernigan; David G Kleinbaum; Trish M Perl; Harold C Standiford; Arjun Srinivasan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

5.  Extra length of stay and costs because of health care-associated infections at a German university hospital.

Authors:  Habibollah Arefian; Stefan Hagel; Steffen Heublein; Florian Rissner; André Scherag; Frank Martin Brunkhorst; Ross J Baldessarini; Michael Hartmann
Journal:  Am J Infect Control       Date:  2016-02       Impact factor: 2.918

Review 6.  Severe sepsis and septic shock in the elderly: An overview.

Authors:  Prashant Nasa; Deven Juneja; Omender Singh
Journal:  World J Crit Care Med       Date:  2012-02-04

7.  Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit.

Authors:  Ji Ye Jung; Moo Suk Park; Song Ee Kim; Byung Hoon Park; Ji Young Son; Eun Young Kim; Joo Eun Lim; Sang Kook Lee; Sang Hoon Lee; Kyung Jong Lee; Young Ae Kang; Se Kyu Kim; Joon Chang; Young Sam Kim
Journal:  BMC Infect Dis       Date:  2010-07-30       Impact factor: 3.090

8.  Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care.

Authors:  Jennifer Townsend; An Na Park; Rita Gander; Kathleen Orr; Doramarie Arocha; Song Zhang; David E Greenberg
Journal:  Open Forum Infect Dis       Date:  2015-03-12       Impact factor: 3.835

Review 9.  Treatment of bloodstream infections in ICUs.

Authors:  Jean-François Timsit; Jean-François Soubirou; Guillaume Voiriot; Sarah Chemam; Mathilde Neuville; Bruno Mourvillier; Romain Sonneville; Eric Mariotte; Lila Bouadma; Michel Wolff
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

10.  Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units.

Authors:  Jean Uwingabiye; Mohammed Frikh; Abdelhay Lemnouer; Fatna Bssaibis; Bouchra Belefquih; Adil Maleb; Souhail Dahraoui; Lahcen Belyamani; Abdelouahed Bait; Charki Haimeur; Lhoussain Louzi; Azeddine Ibrahimi; Mostafa Elouennass
Journal:  Pan Afr Med J       Date:  2016-04-15
View more
  7 in total

1.  Risk factors and clinical outcomes for intensive care unit patients with mul-tidrug-resistant Acinetobacter spp. bacteremia.

Authors:  Malbaša Đekić; T Dugandžija; G Dragovac; D Medić; M Paut Kusturica
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

2.  High Frequency of AdeA, AdeB and AdeC Genes among Acinetobacter baumannii Isolates.

Authors:  Reza Ranjbar; Shahin Zayeri; Davoud Afshar
Journal:  Iran J Public Health       Date:  2020-08       Impact factor: 1.429

3.  The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017.

Authors:  Olaniyi Ayobami; Niklas Willrich; Beneditta Suwono; Tim Eckmanns; Robby Markwart
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-19       Impact factor: 4.887

4.  Rapid Killing and Biofilm Inhibition of Multidrug-Resistant Acinetobacter baumannii Strains and Other Microbes by Iodoindoles.

Authors:  Chaitany Jayprakash Raorane; Jin-Hyung Lee; Jintae Lee
Journal:  Biomolecules       Date:  2020-08-14

5.  The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis.

Authors:  Olaniyi Ayobami; Niklas Willrich; Thomas Harder; Iruka N Okeke; Tim Eckmanns; Robby Markwart
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

6.  Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.

Authors:  Habtamu Mekonnen; Abdurahaman Seid; Genet Molla Fenta; Teklay Gebrecherkos
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

7.  Molecular Epidemiology of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex Isolated From Children at the Hospital Infantil de México Federico Gómez.

Authors:  Jetsi Mancilla-Rojano; Sara A Ochoa; Juan Pablo Reyes-Grajeda; Víctor Flores; Oscar Medina-Contreras; Karina Espinosa-Mazariego; Israel Parra-Ortega; Daniela De La Rosa-Zamboni; María Del Carmen Castellanos-Cruz; José Arellano-Galindo; Miguel A Cevallos; Rigoberto Hernández-Castro; Juan Xicohtencatl-Cortes; Ariadnna Cruz-Córdova
Journal:  Front Microbiol       Date:  2020-10-15       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.